AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Forest Laboratories receives FDA approvable letter for oxycodone HCl/ibuprofen.
(From Chemical Business NewsBase - Press Release)
Forest Laboratories Inc announced that the US Food and Drug Administration (FDA) concluded the company's New Drug Application for its investigational treatment oxycodone HCl/ibuprofen was approvable. Oxycodone HCl/ibuprofen is a patented combination of oxycodone, an opioid analgesic, and ibuprofen, one of the most widely used non-steroidal anti-inflammatory drugs. Oxycodone HCl/ibuprofen is licensed to Forest Laboratories …
-
- Press Release: Forest Laboratories submits New Drug Application for oxycodone...
-
News wire article from: Chemical Business Newsbase
December 20, 2001
700+ words
-
- New Combunox (Oxycodone HCl and Ibuprofen) Tablets (CII) now available for...
-
News wire article from: Asia Africa Intelligence Wire
March 21, 2005
700+ words
-
- FDA approves Combunox (Oxycodone HCl and Ibuprofen) Tablets (CII) for the...
-
News wire article from: Asia Africa Intelligence Wire
November 26, 2004
700+ words
-
- Forest Laboratories Inc and Cypress Bioscience Inc announce results of Phase...
-
News wire article from: Asia Africa Intelligence Wire
September 28, 2005
700+ words
-
- H. Lundbeck A/S and Forest Laboratories, Inc. file lawsuit against Caraco...
-
News wire article from: Europe Intelligence Wire
July 11, 2006
700+ words
